Letrozole 2.5 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 2.5 mg
Reference Brands: Femara® (US & EU)
Category: Oncology Cancer Care
Letrozole (brand name Femara®) is an oral aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. Approved in the US and EU, it comes in a 2.5 mg tablet. Widely available through B2B pharma channels, Letrozole is GMP-compliant and reliably supplied to hospitals and oncology centers at competitive prices
Manufacture or export Letrozole? List it or send an offer →
Product Description:
Letrozole is a non-steroidal aromatase inhibitor. After menopause the ovaries stop producing oestrogen, but small amounts are still made by the aromatase enzyme converting androgens in fat, muscle and the tumour itself — enough to sustain a hormone-receptor-positive breast cancer. Letrozole blocks that enzyme reversibly and reduces circulating oestrogen by more than ninety-five per cent, which is why it outperforms tamoxifen in postmenopausal women.
It is used as adjuvant treatment for early hormone receptor-positive breast cancer, for advanced disease, and increasingly with CDK4/6 inhibitors. It has a second and quite different use: in premenopausal women it triggers ovulation by removing oestrogen's negative feedback on the pituitary, and in polycystic ovary syndrome it now outperforms clomiphene for live birth rates. Adverse effects reflect oestrogen deprivation — hot flushes, arthralgia severe enough to cause many women to stop, vaginal dryness, and progressive bone loss requiring densitometry.
Sourcing notes. Long off patent and widely multi-source, so price is the competitive variable. Treatment courses of five years or more in the adjuvant setting give highly predictable repeat demand. The fertility indication is a separate market with different buyers and different regulatory positioning — it is off-label in many countries. Oral tablets, room temperature.
Also known as: letrozol (Spanish, Portuguese, Indonesian), létrozole (French), Letrozol (German), letrozolo (Italian), letrozole (Vietnamese), летрозол (Russian), ليتروزول (Arabic), 来曲唑 (Chinese), レトロゾール (Japanese).
Letrozole — third party manufacturing & bulk supply
Letrozole 2.5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Letrozole is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Letrozole listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Letrozole →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
El letrozol es un inhibidor de la aromatasa no esteroideo que reduce la producción de estrógenos y se utiliza para tratar el cáncer de mama con receptores hormonales positivos en mujeres posmenopáusicas, tanto en el tratamiento adyuvante como en la enfermedad avanzada. Es un medicamento de prescripción que se usa bajo la supervisión de un oncólogo. PharmaTradz conecta a importadores, distribuidores y hospitales con licencia con fabricantes de letrozol que cuentan con certificación GMP.
O letrozol é um inibidor da aromatase não esteroide que reduz a produção de estrogênio e é usado no tratamento do câncer de mama com receptores hormonais positivos em mulheres na pós-menopausa, tanto na terapia adjuvante quanto na doença avançada. É um medicamento de venda sob prescrição, usado sob supervisão de um oncologista. A PharmaTradz conecta importadores, distribuidores e hospitais licenciados a fabricantes de letrozol com certificação GMP.
Le létrozole est un inhibiteur non stéroïdien de l'aromatase qui diminue la production d'œstrogènes ; il est utilisé dans le traitement du cancer du sein hormonodépendant chez la femme ménopausée, en situation adjuvante comme au stade avancé. Ce médicament est délivré sur ordonnance et utilisé sous la surveillance d'un oncologue. PharmaTradz met en relation les importateurs, distributeurs et hôpitaux agréés avec des fabricants de létrozole certifiés BPF (GMP).
Related Products
Methotrexate
Strength:
Tablets: 2.5 mg, 5 mg, 10 mg, 15 mg; IV/IM: 25 mg/mL
Form: Oral tablets, Injection (IV and IM)
Reference Brands: Rheumatrex® (EU & US)
View DetailsLenalidomide Capsule
Strength:
2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg
Form: Oral Capsules
Reference Brands: Revlimid® (EU & US)
View DetailsPaclitaxel Liposomal
Strength:
-
Form: Injection (IV administration)
Reference Brands: -
View DetailsTopotecan Capsule
Strength:
Capsule: 1 mg, 2.5 mgL
Form: Oral capsules
Reference Brands: Hycamtin® (EU & US)
View DetailsSerplulimab Injection
Strength:
100 mg/10 mL
Form: Concentrate vial (IV infusion)
Reference Brands: Hetronifly (EU), Hansizhuang (China)
View DetailsGedatolisib for Injection
Strength:
180 mg
Form: Powder vial (IV infusion)
Reference Brands: Revtorpyk
View DetailsUsually answered within 48 hours | GMP documents shared before you commit